Search results
Radyus Research and Dt&CRO Join Forces to Pave Way for South Korean Biotech Companies into the U.S....
Loudoun Times-Mirror· 21 hours agoRadyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract ...
Q1 2024 MaxCyte Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoLooking specifically at the quarter, the core business performed as expected across cell therapy and drug discovery. We saw a return to growth in our cell therapy business ...
Insider Sale: Segment President Marc Prieur Sells 3,200 Shares of AptarGroup Inc (ATR)
GuruFocus.com via Yahoo Finance· 7 hours agoAptarGroup Inc (NYSE:ATR), a company specializing in the design and manufacturing of a broad range...
Candy company recalls products due to salmonella risk
Medical Xpress· 1 hour agoPalmer Candy Company of Sioux City, Iowa, is recalling "white coated confectionary items" because...
Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains
GuruFocus.com via Yahoo Finance· 41 minutes agoCompany Overview Veru Inc. is at the forefront of biopharmaceutical innovation, focusing on metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The ...
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
GuruFocus.com via Yahoo Finance· 5 hours agoBiologics and drug delivery revenue grew by 61% due to expanded offerings. Capital equipment and software revenue surged by 255% due to multiple placements...59%, demonstrating ...
Q1 2024 Abcellera Biologics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 hours agoWe are on track to start our first engineering runs at our facility next year. And finally, our third priority is executing partnerships that we view as strategic to our long-term vision of ...
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
GuruFocus.com via Yahoo Finance· 37 minutes agoSeres Therapeutics Inc (NASDAQ:MCRB) disclosed its first-quarter financial results for 2024 on May 8, 2024, revealing significant developments in its commercial and clinical operations. The ...
It's time we asked why Williamson County doesn't have a medical examiner | Opinion
Austin American-Statesman via Yahoo News· 2 hours agoI felt this acutely last week, because I was the on-call judge, and I processed two deaths within 15...
Earnings call: X4 Pharmaceuticals reports Q1 2024 results and drug developments By Investing.com
Investing.com· 16 hours agoX4 Pharmaceuticals (NASDAQ:XFOR) has announced its financial results for the first quarter of 2024...
